News

University of Texas at Austin molecular biosciences professor Jason McLellan was selected as a finalist for the 2022 Blavatnik National Awards for Young Scientists.

Lauren Ehrlich, associate professor of molecular biosciences, has been named one of the Texas 10 by The Alcalde, the University of Texas at Austin alumni magazine. Alumni nominate professors who inspired them and went above and beyond for their students.

​The National Science Foundation (NSF) awards a Graduate Research Fellowship to students who plan on pursuing a research-based master's or Ph.D. program in a STEM-related field. The fellowship is awarded to exceptional individuals and will support them in elevating their research with the goal of furthering advancements that will transform the future.

An enzyme variant created by engineers and scientists at The University of Texas at Austin can break down environment-throttling plastics that typically take centuries to degrade in just a matter of hours to days.

John Wallingford, professor of molecular biosciences at The University of Texas at Austin, and his team used a process called live cell imaging to make observations about how a developing embryo transforms from its early ball shape into a more elongated shape with a distinct head and rear. Disruptions to this process in human embryos can lead to birth defects.

Three undergraduate students from the College of Natural Sciences have been awarded the 2022 Barry Goldwater Scholarship, a prestigious national scholarship given to students pursuing careers in the natural sciences, mathematics and engineering fields. Olivia Conway, Aniket Sanghi, and Kevin Zhou are among 475 college students from across the country to receive the scholarship for the 2022 competition.

John Wallingford, professor of molecular biosciences at The University of Texas at Austin, has been awarded a fellowship by the John Simon Guggenheim Memorial Foundation.

​Some of the same researchers at The University of Texas at Austin who created a key to all coronavirus vaccines used in the U.S. have made a similar advance against the human metapneumovirus (hMPV), one of a handful of remaining respiratory viruses for which there is currently no vaccine.

When you think of the type of labs driving biomedical discoveries, you may envision beakers and test tubes filled with a rainbow of chemicals, where much of the magic of scientific experimentation takes place. However, those chemicals are expensive. Pure forms can be difficult to manufacture, ship and store, and they often have to be ordered in very large quantities, which creates barriers to scientific experimentation and advancement.

One of the grand challenges with using CRISPR-based gene editing on humans is that the molecular machinery sometimes makes changes to the wrong section of a host's genome, creating the possibility that an attempt to repair a genetic mutation in one spot in the genome could accidentally create a dangerous new mutation in another.